ArticleBMC bioinformatics2026
RCDRank: a web server to prioritize regulated cell death modalities.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRegulated cell death (RCD) maintains cellular homeostasis and tissue integrity, playing a pivotal role in both health and disease. A variety of RCD subroutines have been identified, each characterized by distinct molecular and morphological features. These cell death modalities do not operate in isolation. Instead, they interact with one another in complex ways. This interaction leads to crosstalk through interconnected and often overlapping signaling pathways. Multiple forms of RCD can coexist within the same disease, influencing various cell types or even the same cell type either synchronously or sequentially. Understanding the intricate dynamics of RCD is of high importance. However, it is challenging to discern the relative contribution of various RCD modalities within the specific biological context. This necessitates the development of advanced methodologies to systematically analyze the priority of RCD pathways in various cellular environments. MAIN: In the present study, we first created a manually curated collection of gene sets for 18 well-characterized RCD modes. We then estimated the significance of each RCD pathway by combining the results of seven gene set enrichment tests via the Tippet p-value combination approach. Afterward, the consensus of enrichment for each RCD pathway across tests was evaluated using robust rank aggregation. The priorities of RCD were subsequently resolved by considering both the combined p value and the consensus score. The reliability of the proposed approach was validated by applying it to explore the RCD modes in intracranial aneurysms. Finally, a user-friendly web application was created for researchers worldwide.
conclusionOur study offers a new way to reveal complicated RCD modalities in specific biological settings. The web server is freely accessible at https://www.zhounan.org/rcdrank.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.